Pages with the fewest revisions

From The School of Biomedical Sciences Wiki
Jump to: navigation, search

Showing below up to 500 results starting with #1.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. C-terminus ‎(2 revisions)
  2. Megakaryocytes ‎(2 revisions)
  3. Intrinsic Pathway ‎(2 revisions)
  4. Complementation test ‎(2 revisions)
  5. Sex linkage ‎(2 revisions)
  6. Fugu Rubripes ‎(2 revisions)
  7. Metabolic processes ‎(2 revisions)
  8. Quiescence ‎(2 revisions)
  9. Isolating DNA ‎(2 revisions)
  10. G protein (Gs) ‎(2 revisions)
  11. Randomised controlled trials ‎(2 revisions)
  12. Acidity ‎(2 revisions)
  13. Reduction ‎(2 revisions)
  14. Trisomys ‎(2 revisions)
  15. DGTP ‎(2 revisions)
  16. Retinitis pigmentosa ‎(2 revisions)
  17. Equational Division ‎(2 revisions)
  18. Linear relationship ‎(2 revisions)
  19. Postsynaptic neurone ‎(2 revisions)
  20. Alkane ‎(2 revisions)
  21. Hypoglycaemia ‎(2 revisions)
  22. Oxidising agent ‎(2 revisions)
  23. Chimerism ‎(2 revisions)
  24. Amine ‎(2 revisions)
  25. Deoxynucleoside triphosphate ‎(2 revisions)
  26. Natural killer cells ‎(2 revisions)
  27. Prostacyclin ‎(2 revisions)
  28. Vitamins ‎(2 revisions)
  29. Anabolic ‎(2 revisions)
  30. Inositiol 1,4,5 triphosphate ‎(2 revisions)
  31. HINDIII ‎(2 revisions)
  32. Neuromuscular junctions ‎(2 revisions)
  33. Selenocysteine ‎(2 revisions)
  34. X-ray diffraction ‎(2 revisions)
  35. DsRNA ‎(2 revisions)
  36. Phosphatases ‎(2 revisions)
  37. Tracheotomy ‎(2 revisions)
  38. Histamine receptors ‎(2 revisions)
  39. Recepter Tyrosine Kinases ‎(2 revisions)
  40. Endogenous ‎(2 revisions)
  41. Active immunity ‎(2 revisions)
  42. Charges ‎(2 revisions)
  43. Muscle Twitch ‎(2 revisions)
  44. Lipoprotein ‎(2 revisions)
  45. IGF (Insulin Growth Factor) ‎(2 revisions)
  46. Cholecystokinin ‎(2 revisions)
  47. Biochemistry ‎(2 revisions)
  48. Aminoacyl ‎(2 revisions)
  49. Incomplete dominance ‎(2 revisions)
  50. Parathyroid gland ‎(2 revisions)
  51. Citric Acid Cycle ‎(2 revisions)
  52. Gregory Mendel ‎(2 revisions)
  53. Protein coding genes ‎(2 revisions)
  54. Androgen ‎(2 revisions)
  55. Insulin receptor substrate ‎(2 revisions)
  56. Protein sequence ‎(2 revisions)
  57. Animal cells ‎(2 revisions)
  58. Calcitonin ‎(2 revisions)
  59. Xenophagy ‎(2 revisions)
  60. Thymidine ‎(2 revisions)
  61. Rab ‎(2 revisions)
  62. Keratinocytes ‎(2 revisions)
  63. Open state probability ‎(2 revisions)
  64. Centric fusion ‎(2 revisions)
  65. Restriction digests ‎(2 revisions)
  66. Aldose ‎(2 revisions)
  67. Hydroxylation ‎(2 revisions)
  68. Structural formula ‎(2 revisions)
  69. Primary alcohol ‎(2 revisions)
  70. Uridine ‎(2 revisions)
  71. Dehydration ‎(2 revisions)
  72. Promoters ‎(2 revisions)
  73. Patch clamp techniques ‎(2 revisions)
  74. Bromelain ‎(2 revisions)
  75. Anti-serum ‎(2 revisions)
  76. Pharmacokinetics ‎(2 revisions)
  77. Microtubule motor protein ‎(2 revisions)
  78. Cerebrum ‎(2 revisions)
  79. Multidrug resistance ‎(2 revisions)
  80. DNA transcription ‎(2 revisions)
  81. Chiral ‎(2 revisions)
  82. Valvular Heart Disease ‎(2 revisions)
  83. Amine group ‎(2 revisions)
  84. Deoxynucleotide ‎(2 revisions)
  85. Immunoblotting ‎(2 revisions)
  86. Synthetic ‎(2 revisions)
  87. Chronic myeloid leukaemia ‎(2 revisions)
  88. Hairpin ‎(2 revisions)
  89. Neutrophils ‎(2 revisions)
  90. Self splicing ‎(2 revisions)
  91. Foetus ‎(2 revisions)
  92. Purine ‎(2 revisions)
  93. X-rays ‎(2 revisions)
  94. Non-sister chromatids ‎(2 revisions)
  95. Jejunum ‎(2 revisions)
  96. Endomembrane system ‎(2 revisions)
  97. Pleckstrin homology ‎(2 revisions)
  98. Cystic fibrosis transmembrane regulator ‎(2 revisions)
  99. Host cell ‎(2 revisions)
  100. Spindle assembly checkpoint ‎(2 revisions)
  101. Genetic sequence ‎(2 revisions)
  102. B-Lymphocyte ‎(2 revisions)
  103. Epidermal growth factor ‎(2 revisions)
  104. Tuberculin Test ‎(2 revisions)
  105. Hydrolytic enzymes ‎(2 revisions)
  106. Rous sarcoma ‎(2 revisions)
  107. Aminoacyl-tRNA synthase ‎(2 revisions)
  108. Induced Pluripotent stem cell ‎(2 revisions)
  109. T4 phage ‎(2 revisions)
  110. Fatty acid chain ‎(2 revisions)
  111. Protein crystallization ‎(2 revisions)
  112. Serology ‎(2 revisions)
  113. Xenopus ‎(2 revisions)
  114. ADH ‎(2 revisions)
  115. Catastrophe ‎(2 revisions)
  116. Recessive phenotype ‎(2 revisions)
  117. Staphylococci ‎(2 revisions)
  118. Positive charge ‎(2 revisions)
  119. Uridine Diphosphate Glucose (UDP-glucose) ‎(2 revisions)
  120. Virion ‎(2 revisions)
  121. Amphipathic molecule ‎(2 revisions)
  122. Fibroblast ‎(2 revisions)
  123. Composition of prokaryotic ribosome ‎(2 revisions)
  124. Hematopoietic stem cells ‎(2 revisions)
  125. Sexual reproduction ‎(2 revisions)
  126. Efficacy ‎(2 revisions)
  127. Isomer ‎(2 revisions)
  128. High Altitude Cerebral Edema ‎(2 revisions)
  129. Enantiomers ‎(2 revisions)
  130. Plaque ‎(2 revisions)
  131. Acromegaly ‎(2 revisions)
  132. Sperm ‎(2 revisions)
  133. Leaky junction ‎(2 revisions)
  134. Polygenic ‎(2 revisions)
  135. Van der Waals forces ‎(2 revisions)
  136. Nausea ‎(2 revisions)
  137. Voltage ‎(2 revisions)
  138. Tandem repeats ‎(2 revisions)
  139. Nick ‎(2 revisions)
  140. Purines ‎(2 revisions)
  141. Hepatocytes ‎(2 revisions)
  142. Non-steroidal anti-inflammatory drugs ‎(2 revisions)
  143. Phosphorylation cascade ‎(2 revisions)
  144. Histone ‎(2 revisions)
  145. Mitochondrial ‎(2 revisions)
  146. Endometrium ‎(2 revisions)
  147. Genetic testing ‎(2 revisions)
  148. Resistance ‎(2 revisions)
  149. Polynucleotides ‎(2 revisions)
  150. Checkpoint pathways ‎(2 revisions)
  151. Glucose-1-phosphate ‎(2 revisions)
  152. Unipotent ‎(2 revisions)
  153. IL-6 ‎(2 revisions)
  154. P53 gene ‎(2 revisions)
  155. Surival Factors ‎(2 revisions)
  156. Rubidium ‎(2 revisions)
  157. Exonuclease ‎(2 revisions)
  158. Induced fit mechanism ‎(2 revisions)
  159. TATA-binding protein ‎(2 revisions)
  160. Group 1 metals ‎(2 revisions)
  161. Sanger Method ‎(2 revisions)
  162. Complement ‎(2 revisions)
  163. Calcium 'Puffs' ‎(2 revisions)
  164. Pyruvate Kinase ‎(2 revisions)
  165. Xist ‎(2 revisions)
  166. Heteroplasmy ‎(2 revisions)
  167. Skeletal Muscle ‎(2 revisions)
  168. GLUT4 ‎(2 revisions)
  169. OH group ‎(2 revisions)
  170. Catecholamines ‎(2 revisions)
  171. Reciprocal cross ‎(2 revisions)
  172. Optical isomer ‎(2 revisions)
  173. Epithelia ‎(2 revisions)
  174. Positive ion ‎(2 revisions)
  175. Alexander Fleming ‎(2 revisions)
  176. Urinary tract infection ‎(2 revisions)
  177. N terminal ‎(2 revisions)
  178. Extracellular fluid ‎(2 revisions)
  179. M. Musculus ‎(2 revisions)
  180. Meiosis II ‎(2 revisions)
  181. Protons ‎(2 revisions)
  182. Heme ‎(2 revisions)
  183. Non-Communicable Disease ‎(2 revisions)
  184. Egg cell ‎(2 revisions)
  185. Coronary Heart Disease ‎(2 revisions)
  186. Galactosemia ‎(2 revisions)
  187. Astrocytes ‎(2 revisions)
  188. Kinetochores ‎(2 revisions)
  189. Moles ‎(2 revisions)
  190. Globin ‎(2 revisions)
  191. Sugar-phosphate backbone ‎(2 revisions)
  192. Evolutionary origin of chloroplasts and mitochondria ‎(2 revisions)
  193. ProSite ‎(2 revisions)
  194. Saccharomyces pombe ‎(2 revisions)
  195. Blunt end ‎(2 revisions)
  196. Prosthetic group ‎(2 revisions)
  197. Voltage-gated ion channel ‎(2 revisions)
  198. Tendon ‎(2 revisions)
  199. Nickase ‎(2 revisions)
  200. Semi-permeable membrane ‎(2 revisions)
  201. Thin layer chromatography ‎(2 revisions)
  202. Signalling ‎(2 revisions)
  203. Mitochondrial matrix ‎(2 revisions)
  204. Triamterene ‎(2 revisions)
  205. Cytidine triphosphate ‎(2 revisions)
  206. Housekeeping gene ‎(2 revisions)
  207. Spindle microtubles ‎(2 revisions)
  208. Epidermolysis bullosa simplex ‎(2 revisions)
  209. Leucocyte ‎(2 revisions)
  210. Streptococci ‎(2 revisions)
  211. Ethanal ‎(2 revisions)
  212. Pregnancy ‎(2 revisions)
  213. Daughter cell ‎(2 revisions)
  214. S-Phase ‎(2 revisions)
  215. Exonucleases ‎(2 revisions)
  216. Diakinesis ‎(2 revisions)
  217. Induced fit model ‎(2 revisions)
  218. Nephron ‎(2 revisions)
  219. Male ‎(2 revisions)
  220. Disulfide bond ‎(2 revisions)
  221. Anions ‎(2 revisions)
  222. Complementarity-determining regions ‎(2 revisions)
  223. Calcium channel ‎(2 revisions)
  224. GLUT5 ‎(2 revisions)
  225. Radiation ‎(2 revisions)
  226. Transgenic animal ‎(2 revisions)
  227. Adensoine ‎(2 revisions)
  228. Optical isomerism ‎(2 revisions)
  229. Chemokines ‎(2 revisions)
  230. Ribosome intiation ‎(2 revisions)
  231. Imac chromatography ‎(2 revisions)
  232. Chromosome 17 ‎(2 revisions)
  233. Viruses ‎(2 revisions)
  234. Amphiphilic ‎(2 revisions)
  235. Innate Immune Response ‎(2 revisions)
  236. The Patch Clamp Technique ‎(2 revisions)
  237. 100,000 genome project ‎(2 revisions)
  238. Heme biosynthetic pathway ‎(2 revisions)
  239. Phospholipid membrane ‎(2 revisions)
  240. Titration ‎(2 revisions)
  241. Ras pathway ‎(2 revisions)
  242. Asymmetric carbon ‎(2 revisions)
  243. Okizaki fragment ‎(2 revisions)
  244. Monoamine neurotransmitters ‎(2 revisions)
  245. Leber's Hereditary Optic Neuropathy ‎(2 revisions)
  246. Troponin C ‎(2 revisions)
  247. Bacterial flagellum ‎(2 revisions)
  248. Alkyl group ‎(2 revisions)
  249. Rod cells ‎(2 revisions)
  250. Amino Acids ‎(2 revisions)
  251. Anaerobic ‎(2 revisions)
  252. Tendons ‎(2 revisions)
  253. Semiconservative replication ‎(2 revisions)
  254. Follicle stimulating hormone ‎(2 revisions)
  255. XYY syndrome ‎(2 revisions)
  256. Thomas Cech ‎(2 revisions)
  257. Signalling cascade ‎(2 revisions)
  258. Carbon monoxide ‎(2 revisions)
  259. Joseph lister ‎(2 revisions)
  260. Gastrointestinal tract ‎(2 revisions)
  261. Leucocytes ‎(2 revisions)
  262. Glucose 1-phosphate ‎(2 revisions)
  263. Unsaturated Fats ‎(2 revisions)
  264. Daughter cells ‎(2 revisions)
  265. Exosome ‎(2 revisions)
  266. Diamond ‎(2 revisions)
  267. Infection ‎(2 revisions)
  268. Classification ‎(2 revisions)
  269. Malignancy ‎(2 revisions)
  270. Watson-Crick pairs ‎(2 revisions)
  271. Proteoglycan ‎(2 revisions)
  272. Domain ‎(2 revisions)
  273. Sertraline ‎(2 revisions)
  274. Y-linked disorders ‎(2 revisions)
  275. Antithrombin III ‎(2 revisions)
  276. EcoR1 ‎(2 revisions)
  277. Phosphoenolpyruvate ‎(2 revisions)
  278. Ketose ‎(2 revisions)
  279. Transgenic bacteria ‎(2 revisions)
  280. Acetyl group ‎(2 revisions)
  281. Subst ‎(2 revisions)
  282. Gluten ‎(2 revisions)
  283. Primer ‎(2 revisions)
  284. Aluminium ‎(2 revisions)
  285. Properties of Action Potentials ‎(2 revisions)
  286. Innate immune response ‎(2 revisions)
  287. Neurons ‎(2 revisions)
  288. Secondary messenger ‎(2 revisions)
  289. CFTR channel ‎(2 revisions)
  290. Flagellum ‎(2 revisions)
  291. Wuchereria bancrofti ‎(2 revisions)
  292. Canis familiaris ‎(2 revisions)
  293. Electrically exciteable cells ‎(2 revisions)
  294. Tolerance ‎(2 revisions)
  295. Corpus luteum ‎(2 revisions)
  296. High blood pressure ‎(2 revisions)
  297. Endocrine glands ‎(2 revisions)
  298. Spermatozoa ‎(2 revisions)
  299. Enzyme-linked receptors ‎(2 revisions)
  300. Leber Congenital Amaurosis ‎(2 revisions)
  301. Aerobic ‎(2 revisions)
  302. Erythrocytes ‎(2 revisions)
  303. Ubiquitin-activating enzyme E3 ‎(2 revisions)
  304. Alkylation ‎(2 revisions)
  305. Glycogen synthesis ‎(2 revisions)
  306. Immunogold labelling ‎(2 revisions)
  307. Systolic pressure ‎(2 revisions)
  308. Necrotising fasciitis ‎(2 revisions)
  309. Anaerobic respiration ‎(2 revisions)
  310. X Chromosome Inactivation ‎(2 revisions)
  311. Connexins ‎(2 revisions)
  312. Arteriole ‎(2 revisions)
  313. Photoreceptors ‎(2 revisions)
  314. Histone Acetyltransferases ‎(2 revisions)
  315. Mitogens ‎(2 revisions)
  316. Tricyclic antidepressants ‎(2 revisions)
  317. Acyl group ‎(2 revisions)
  318. Monoploidy ‎(2 revisions)
  319. Basal bodies ‎(2 revisions)
  320. Lymphomas ‎(2 revisions)
  321. Prolactin ‎(2 revisions)
  322. Passive transporter ‎(2 revisions)
  323. TFIIA ‎(2 revisions)
  324. Growth factor receptor ‎(2 revisions)
  325. Bovine spongiform encephalopathy ‎(2 revisions)
  326. Anomer ‎(2 revisions)
  327. Complementary base pairing ‎(2 revisions)
  328. Mesoderm ‎(2 revisions)
  329. Isoelectric Point ‎(2 revisions)
  330. Microbiota ‎(2 revisions)
  331. Elute ‎(2 revisions)
  332. Placenta ‎(2 revisions)
  333. Transgenic mice ‎(2 revisions)
  334. Cation channels ‎(2 revisions)
  335. Centromeres ‎(2 revisions)
  336. Oxidative damage ‎(2 revisions)
  337. Basophils ‎(2 revisions)
  338. Eukaryotic ‎(2 revisions)
  339. Imidazole ‎(2 revisions)
  340. Amylase ‎(2 revisions)
  341. T lymphocyte ‎(2 revisions)
  342. Capillaries ‎(2 revisions)
  343. Phosphoric acid ‎(2 revisions)
  344. Corticosteroids ‎(2 revisions)
  345. High density lipoproteins ‎(2 revisions)
  346. Sodium-calcium Exchanger ‎(2 revisions)
  347. Rate of reaction ‎(2 revisions)
  348. Genetic disorders ‎(2 revisions)
  349. Multipotent ‎(2 revisions)
  350. Bacterial meningitis ‎(2 revisions)
  351. Myosin light chain kinase ‎(2 revisions)
  352. T-Lymphocyte ‎(2 revisions)
  353. Cis-regulatory element ‎(2 revisions)
  354. Nedd4 ‎(2 revisions)
  355. Termination ‎(2 revisions)
  356. Column chromatography ‎(2 revisions)
  357. Ca2+ ions ‎(2 revisions)
  358. Antigenic variation ‎(2 revisions)
  359. Heredity ‎(2 revisions)
  360. GABA receptors ‎(2 revisions)
  361. Methyl ‎(2 revisions)
  362. K+ leak channel ‎(2 revisions)
  363. Absorbance ‎(2 revisions)
  364. Pluripotent stem cells ‎(2 revisions)
  365. Epigenome ‎(2 revisions)
  366. Loci ‎(2 revisions)
  367. IPTG ‎(2 revisions)
  368. Amniocentisis ‎(2 revisions)
  369. Patau's Syndrome ‎(2 revisions)
  370. Bowman's capsule ‎(2 revisions)
  371. Female ‎(2 revisions)
  372. Intracellular compartment ‎(2 revisions)
  373. Tetrad ‎(2 revisions)
  374. Sex-chromosomes ‎(2 revisions)
  375. Calcium phosphate ‎(2 revisions)
  376. Frequency ‎(2 revisions)
  377. Ectoderm ‎(2 revisions)
  378. ADP ribose ‎(2 revisions)
  379. Conventional current ‎(2 revisions)
  380. Skull ‎(2 revisions)
  381. Recombinant frequency ‎(2 revisions)
  382. Autophosphorylation ‎(2 revisions)
  383. Hydrocarbon ‎(2 revisions)
  384. Mouse ‎(2 revisions)
  385. Posterior pituitary gland ‎(2 revisions)
  386. Aliphatic ‎(2 revisions)
  387. Vaccination ‎(2 revisions)
  388. Alzheimer's ‎(2 revisions)
  389. SOS ‎(2 revisions)
  390. F-actin ‎(2 revisions)
  391. X-linked recessive ‎(2 revisions)
  392. Concentration Gradient ‎(2 revisions)
  393. Metals ‎(2 revisions)
  394. Zymogen ‎(2 revisions)
  395. HindIII ‎(2 revisions)
  396. Cas ‎(2 revisions)
  397. Endocrine tissue ‎(2 revisions)
  398. Plasma proteins ‎(2 revisions)
  399. Cell differentiation ‎(2 revisions)
  400. Chargaff's Rules ‎(2 revisions)
  401. Reverse primer ‎(2 revisions)
  402. Pre-Initiation Complex ‎(2 revisions)
  403. Hypotonic Solution ‎(2 revisions)
  404. Macrophages ‎(2 revisions)
  405. Voluntary movement ‎(2 revisions)
  406. Analogue ‎(2 revisions)
  407. Peptide hormones ‎(2 revisions)
  408. Interleukin 10 ‎(2 revisions)
  409. Personalised Healthcare ‎(2 revisions)
  410. Haworth projection ‎(2 revisions)
  411. Forward primer ‎(2 revisions)
  412. Memory B cell ‎(2 revisions)
  413. Phosphatidylethanolamine ‎(2 revisions)
  414. Threshold potential ‎(2 revisions)
  415. Consanguineous ‎(2 revisions)
  416. Herpes ‎(2 revisions)
  417. Kaposi's sarcoma ‎(2 revisions)
  418. Histone acetyltransferases ‎(2 revisions)
  419. Cytokinesis ‎(2 revisions)
  420. Oocyte ‎(2 revisions)
  421. Genomic DNA ‎(2 revisions)
  422. Polyploidy ‎(2 revisions)
  423. DNA methylase ‎(2 revisions)
  424. Hydroxide ‎(2 revisions)
  425. Ribonuceic acid ‎(2 revisions)
  426. Allostery ‎(2 revisions)
  427. Blastocyst ‎(2 revisions)
  428. Amoeba ‎(2 revisions)
  429. Dideoxy sequencing ‎(2 revisions)
  430. Growth hormone ‎(2 revisions)
  431. Filopodia ‎(2 revisions)
  432. Tetrasomy ‎(2 revisions)
  433. Complementary strand ‎(2 revisions)
  434. Heat shock protein ‎(2 revisions)
  435. Fructose ‎(2 revisions)
  436. Isoelectric point ‎(2 revisions)
  437. Thyroxine ‎(2 revisions)
  438. Ran ‎(2 revisions)
  439. Kidneys ‎(2 revisions)
  440. Transition metal ‎(2 revisions)
  441. Current loops ‎(2 revisions)
  442. Caveolae ‎(2 revisions)
  443. Adipocyte ‎(2 revisions)
  444. D-isomer ‎(2 revisions)
  445. Light ‎(2 revisions)
  446. DNA template strand ‎(2 revisions)
  447. Dengue fever ‎(2 revisions)
  448. Immune complex ‎(2 revisions)
  449. SRY Gene ‎(2 revisions)
  450. Dilution formula ‎(2 revisions)
  451. HCN channel ‎(2 revisions)
  452. Scientific journals ‎(2 revisions)
  453. Secretory vesicles ‎(2 revisions)
  454. Melanocytes ‎(2 revisions)
  455. 30S ‎(2 revisions)
  456. Hemophilus influenzae ‎(2 revisions)
  457. Α-D-glucopyranose ‎(2 revisions)
  458. Cosmid ‎(2 revisions)
  459. Atomic mass ‎(2 revisions)
  460. Transpeptidase ‎(2 revisions)
  461. Sphygmomanometer ‎(2 revisions)
  462. DNA Sequencing ‎(2 revisions)
  463. Chargaff's rule ‎(2 revisions)
  464. Glucocorticoid ‎(2 revisions)
  465. Pre-eclampsia ‎(2 revisions)
  466. Hypoxanthine ‎(2 revisions)
  467. Lymph fluid ‎(2 revisions)
  468. Amino acid residues ‎(2 revisions)
  469. Parasites ‎(2 revisions)
  470. Cisternae ‎(2 revisions)
  471. Grb2 ‎(2 revisions)
  472. Boiling point ‎(2 revisions)
  473. Fasciculi ‎(2 revisions)
  474. Macula densa ‎(2 revisions)
  475. Von Gierke disease ‎(2 revisions)
  476. Anhydride ‎(2 revisions)
  477. Diuretics ‎(2 revisions)
  478. Sepsis ‎(2 revisions)
  479. X chromosomes ‎(2 revisions)
  480. Antihemophilic Factor ‎(2 revisions)
  481. Nucleous ‎(2 revisions)
  482. Lactate ‎(2 revisions)
  483. BRCA-1 ‎(2 revisions)
  484. Chemiluminescence ‎(2 revisions)
  485. Ribonuclease H ‎(2 revisions)
  486. Alopecia areata ‎(2 revisions)
  487. PI3Ka domain ‎(2 revisions)
  488. NAPQI ‎(2 revisions)
  489. Expect (E) value ‎(2 revisions)
  490. Lysis ‎(2 revisions)
  491. Clip ‎(2 revisions)
  492. Growth hormone releasing factor ‎(2 revisions)
  493. Nerve growth factor ‎(2 revisions)
  494. Brainstem ‎(2 revisions)
  495. Fermentation ‎(2 revisions)
  496. Filtrate ‎(2 revisions)
  497. Protien ‎(2 revisions)
  498. Wilson's Disease ‎(2 revisions)
  499. Anterior pituitary gland ‎(2 revisions)
  500. Intracellular receptors ‎(2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Personal tools
Namespaces
Variants
Views
Actions
Navigation
Toolbox